Ortho Clinical Diagnostics Holdings plc (OCDX)
Price:
17.63 USD
( + 0.16 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Syneos Health, Inc.
VALUE SCORE:
0
2nd position
GRAIL, Inc.
VALUE SCORE:
9
The best
Medpace Holdings, Inc.
VALUE SCORE:
9
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
Ortho Clinical Diagnostics Holdings plc provides in-vitro diagnostics solutions to the clinical laboratory and transfusion medicine communities worldwide. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening instruments and tests for blood and plasma screening for infectious diseases. The company is also involved in the provision of contract manufacturing and orthocare services. Its products are used in hospitals, laboratories, clinics, blood banks, and donor centers. Ortho Clinical Diagnostics Holdings plc was founded in 1939 and is headquartered in Raritan, New Jersey.
NEWS
Ortho Clinical Diagnostics Holdings PLC (OCDX) CEO Chris Smith on Q1 2022 Results - Earnings Call Transcript
seekingalpha.com
2022-05-07 18:23:05Ortho Clinical Diagnostics Holdings PLC (NASDAQ:OCDX ) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Bryan Brokmeier - Vice President, Investor Relations Chris Smith - Chairman and Chief Executive Officer Joseph Busky - Chief Financial Officer Operator Welcome to the Ortho Clinical Diagnostics First Quarter 2022 Earnings Conference Call and Webcast. At this time, all participants lines are in a listen-only mode.
Why Ortho Clinical (OCDX) Could Beat Earnings Estimates Again
zacks.com
2022-04-28 13:32:18Ortho Clinical (OCDX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
OCDX vs. DOCS: Which Stock Is the Better Value Option?
zacks.com
2022-04-01 13:23:31OCDX vs. DOCS: Which Stock Is the Better Value Option?
Ortho Clinical (OCDX) Upgraded to Strong Buy: Here's What You Should Know
zacks.com
2022-03-24 13:33:10Ortho Clinical (OCDX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
New Strong Buy Stocks for March 24th
zacks.com
2022-03-24 09:47:10ASRT, CPRI, GRIN, OCDX, and KN have been added to the Zacks Rank #1 (Strong Buy) List on March 24, 2022.
OCDX vs. PGNY: Which Stock Should Value Investors Buy Now?
zacks.com
2022-03-15 12:48:09OCDX vs. PGNY: Which Stock Is the Better Value Option?
ORTHO CLINICAL INVESTOR ALERT - Kuznicki Law PLLC Investigates Adequacy of Price and Process in Proposed Sale of Ortho Clinical Diagnostics Holdings plc - OCDX
businesswire.com
2022-03-10 17:23:00CEDARHURST, N.Y.--(BUSINESS WIRE)--Kuznicki Law PLLC is investigating the proposed sale of Ortho Clinical Diagnostics Holdings plc (NasdaqGS: OCDX) to Quidel Corporation (NasdaqGS: QDEL). Under the terms of the proposed transaction, shareholders of Ortho will receive only $7.14 in cash and 0.1055 shares of common stock in the combined company for each share of Ortho that they own. Kuznicki Law is seeking to determine whether this consideration and the process that led to it are adequate, or whe
Will Ortho Clinical (OCDX) Gain on Rising Earnings Estimates?
zacks.com
2022-02-25 13:50:14Ortho Clinical (OCDX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
New Strong Buy Stocks for February 18th
zacks.com
2022-02-18 10:05:27CIVI, CLW, OCDX, WCC, and DBI have been added to the Zacks Rank #1 (Strong Buy) List on February 18, 2022.
Best Value Stocks to Buy for February 18th
zacks.com
2022-02-18 10:05:13CIVI, DBI, and OCDX made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 18, 2022
Ortho Clinical Diagnostics Holdings PLC (OCDX) CEO Christopher Smith on Q4 2021 Results - Earnings Call Transcript
seekingalpha.com
2022-02-16 22:28:10Ortho Clinical Diagnostics Holdings PLC (OCDX) CEO Christopher Smith on Q4 2021 Results - Earnings Call Transcript
Ortho Clinical Diagnostics (OCDX) Tops Q4 Earnings and Revenue Estimates
zacks.com
2022-02-16 19:19:14Ortho Clinical (OCDX) delivered earnings and revenue surprises of 20% and 0.39%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
OCDX Stock Alert: 9 Things to Know About the Quidel Deal Sending Ortho Clinical Higher
investorplace.com
2021-12-23 12:18:13Quidel will acquire OCDX stock for $24.68 per share and newly issued stock. The transaction will be worth a total of $6 billion.
Medical Equipment Stock Surges on Buyout Buzz
schaeffersresearch.com
2021-12-23 10:28:53The shares of Ortho Clinical Diagnostics Holdings PLC (NASDAQ:OCDX) are up 8.1% to trade at $21.45 last check, after news that Quidel (QDEL) will acquire the company for roughly $6 billion in a cash-and-stock deal -- expanding its portfolio of diagnostic products.
JD.com Is Falling, But an M&A Bid Is Lifting This Small Nasdaq Stock Thursday
fool.com
2021-12-23 09:15:00Find out why the stock market could see more gains.
Quidel To Buy Ortho Clinical Diagnostics For $24.68/Share: Highlights
benzinga.com
2021-12-23 08:16:25Quidel Corp (NASDAQ: QDEL) has agreed to acquire Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) for $24.68 per share in cash and newly issued shares in the combined company, The offer price represents a 25% premium over Ortho's closing price on December 22, 2021.
No data to display
Ortho Clinical Diagnostics Holdings PLC (OCDX) CEO Chris Smith on Q1 2022 Results - Earnings Call Transcript
seekingalpha.com
2022-05-07 18:23:05Ortho Clinical Diagnostics Holdings PLC (NASDAQ:OCDX ) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Bryan Brokmeier - Vice President, Investor Relations Chris Smith - Chairman and Chief Executive Officer Joseph Busky - Chief Financial Officer Operator Welcome to the Ortho Clinical Diagnostics First Quarter 2022 Earnings Conference Call and Webcast. At this time, all participants lines are in a listen-only mode.
Why Ortho Clinical (OCDX) Could Beat Earnings Estimates Again
zacks.com
2022-04-28 13:32:18Ortho Clinical (OCDX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
OCDX vs. DOCS: Which Stock Is the Better Value Option?
zacks.com
2022-04-01 13:23:31OCDX vs. DOCS: Which Stock Is the Better Value Option?
Ortho Clinical (OCDX) Upgraded to Strong Buy: Here's What You Should Know
zacks.com
2022-03-24 13:33:10Ortho Clinical (OCDX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
New Strong Buy Stocks for March 24th
zacks.com
2022-03-24 09:47:10ASRT, CPRI, GRIN, OCDX, and KN have been added to the Zacks Rank #1 (Strong Buy) List on March 24, 2022.
OCDX vs. PGNY: Which Stock Should Value Investors Buy Now?
zacks.com
2022-03-15 12:48:09OCDX vs. PGNY: Which Stock Is the Better Value Option?
ORTHO CLINICAL INVESTOR ALERT - Kuznicki Law PLLC Investigates Adequacy of Price and Process in Proposed Sale of Ortho Clinical Diagnostics Holdings plc - OCDX
businesswire.com
2022-03-10 17:23:00CEDARHURST, N.Y.--(BUSINESS WIRE)--Kuznicki Law PLLC is investigating the proposed sale of Ortho Clinical Diagnostics Holdings plc (NasdaqGS: OCDX) to Quidel Corporation (NasdaqGS: QDEL). Under the terms of the proposed transaction, shareholders of Ortho will receive only $7.14 in cash and 0.1055 shares of common stock in the combined company for each share of Ortho that they own. Kuznicki Law is seeking to determine whether this consideration and the process that led to it are adequate, or whe
Will Ortho Clinical (OCDX) Gain on Rising Earnings Estimates?
zacks.com
2022-02-25 13:50:14Ortho Clinical (OCDX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
New Strong Buy Stocks for February 18th
zacks.com
2022-02-18 10:05:27CIVI, CLW, OCDX, WCC, and DBI have been added to the Zacks Rank #1 (Strong Buy) List on February 18, 2022.
Best Value Stocks to Buy for February 18th
zacks.com
2022-02-18 10:05:13CIVI, DBI, and OCDX made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 18, 2022
Ortho Clinical Diagnostics Holdings PLC (OCDX) CEO Christopher Smith on Q4 2021 Results - Earnings Call Transcript
seekingalpha.com
2022-02-16 22:28:10Ortho Clinical Diagnostics Holdings PLC (OCDX) CEO Christopher Smith on Q4 2021 Results - Earnings Call Transcript
Ortho Clinical Diagnostics (OCDX) Tops Q4 Earnings and Revenue Estimates
zacks.com
2022-02-16 19:19:14Ortho Clinical (OCDX) delivered earnings and revenue surprises of 20% and 0.39%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
OCDX Stock Alert: 9 Things to Know About the Quidel Deal Sending Ortho Clinical Higher
investorplace.com
2021-12-23 12:18:13Quidel will acquire OCDX stock for $24.68 per share and newly issued stock. The transaction will be worth a total of $6 billion.
Medical Equipment Stock Surges on Buyout Buzz
schaeffersresearch.com
2021-12-23 10:28:53The shares of Ortho Clinical Diagnostics Holdings PLC (NASDAQ:OCDX) are up 8.1% to trade at $21.45 last check, after news that Quidel (QDEL) will acquire the company for roughly $6 billion in a cash-and-stock deal -- expanding its portfolio of diagnostic products.
JD.com Is Falling, But an M&A Bid Is Lifting This Small Nasdaq Stock Thursday
fool.com
2021-12-23 09:15:00Find out why the stock market could see more gains.
Quidel To Buy Ortho Clinical Diagnostics For $24.68/Share: Highlights
benzinga.com
2021-12-23 08:16:25Quidel Corp (NASDAQ: QDEL) has agreed to acquire Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) for $24.68 per share in cash and newly issued shares in the combined company, The offer price represents a 25% premium over Ortho's closing price on December 22, 2021.